Literature DB >> 11847181

Which patient should be referred to an electrophysiologist: supraventricular tachycardia.

Richard J Schilling1.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 11847181      PMCID: PMC1767049          DOI: 10.1136/heart.87.3.299

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  32 in total

1.  Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation.

Authors:  S Goldman; P Probst; A Selzer; K Cohn
Journal:  Am J Cardiol       Date:  1975-05       Impact factor: 2.778

2.  Accurate assessment of patient effective radiation dose and associated detriment risk from radiofrequency catheter ablation procedures.

Authors:  K Perisinakis; J Damilakis; N Theocharopoulos; E Manios; P Vardas; N Gourtsoyiannis
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

3.  Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; S Garrigue; A Takahashi; T Lavergne; M Hocini; J T Peng; R Roudaut; J Clémenty
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

Review 4.  Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors:  N Saoudi; F Cosio; A Waldo; S A Chen; Y Iesaka; M Lesh; S Saksena; J Salerno; W Schoels
Journal:  J Cardiovasc Electrophysiol       Date:  2001-07

5.  The natural history of Wolff-Parkinson-White syndrome in 228 military aviators: a long-term follow-up of 22 years.

Authors:  P J Fitzsimmons; P D McWhirter; D W Peterson; W B Kruyer
Journal:  Am Heart J       Date:  2001-09       Impact factor: 4.749

6.  Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs.

Authors:  M N Bathina; S Mickelsen; C Brooks; J Jaramillo; T Hepton; F M Kusumoto
Journal:  Am J Cardiol       Date:  1998-09-01       Impact factor: 2.778

7.  Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter.

Authors:  A Natale; K H Newby; E Pisanó; F Leonelli; R Fanelli; D Potenza; S Beheiry; G Tomassoni
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

8.  Incidence and predictors of atrial flutter in the general population.

Authors:  J Granada; W Uribe; P H Chyou; K Maassen; R Vierkant; P N Smith; J Hayes; E Eaker; H Vidaillet
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

9.  Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.

Authors:  K J Hellestrand; R S Bexton; A W Nathan; R A Spurrell; A J Camm
Journal:  Br Heart J       Date:  1982-08

10.  Determinants of recurrent atrial flutter after cardioversion.

Authors:  R G Pozen; J Pastoriza; J J Rozanski; K M Kessler; R J Myerburg
Journal:  Br Heart J       Date:  1983-07
View more
  1 in total

1.  Radiofrequency catheter ablation of supraventricular tachycardia.

Authors:  Hugh Calkins; V K Ajit Kumar; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2002-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.